title: Is there really an increased risk of early colorectal cancer in women with BRCA1 pathogenic mutations?
authors.affiliation: Department of Genomic Medicine, MAHSC, Institute of Human Development, University of Manchester, St. Mary's Hospital, Manchester, UK.
authors.forename: D G
authors.initials: DG
authors.lastname: Evans
authors.affiliation: Department of Genomic Medicine, MAHSC, Institute of Human Development, University of Manchester, St. Mary's Hospital, Manchester, UK.
authors.forename: T
authors.initials: T
authors.lastname: Clancy
authors.affiliation: Department of Colorectal Surgery, MAHSC, Institute of Human Development, University of Manchester, St. Mary's Hospital, Manchester, UK.
authors.forename: J
authors.initials: J
authors.lastname: Hill
authors.affiliation: Department of Medical Genetics, University of Cambridge, Cambridge, UK.
authors.forename: M
authors.initials: M
authors.lastname: Tischkowitz
mesh_terms: D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000235:genetics*; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D006801:Humans; D009154:Mutation